Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Correlation of creatinine levels in saliva and plasma in normal subjects and renal patients.

Chiou WL, Hsu FH, Westenfelder C, Kurtzman NA.

Res Commun Chem Pathol Pharmacol. 1977 Mar;16(3):549-56.

PMID:
847302
2.

Creatinine VIII: saliva levels of endogenous "true" creatinine in normal subjects.

Chiou WL, Pu FS.

Clin Pharmacol Ther. 1979 Jun;25(6):777-82.

PMID:
445944
4.

Early elevation of lipoprotein(a) levels in chronic renal insufficiency.

De Lima JJ, Maranhão RC, Latrilha Mda C, Diament J, Romão JE, Krieger EM, Pileggi F.

Ren Fail. 1997 Jan;19(1):145-54.

PMID:
9044461
5.

Saliva and plasma levels and plasma protein binding of clofibrinic acid in uremic patients.

Bjornsson TD, Meffin PJ, Peters FA, Blaschke TF.

Clin Pharmacol Ther. 1980 Feb;27(2):230-5.

PMID:
7353345
6.

Serum levels of bone Gla-protein in normal humans and in patients with chronic renal failure.

Sugimoto K, Dohi Y, Dohi K, Yonemasu K, Fujimoto J, Kanauchi M, Yamanaka F, Moriyama T, Ishikawa H.

Miner Electrolyte Metab. 1987;13(3):152-7.

PMID:
3498115
8.

Tear urea nitrogen and creatinine levels in renal patients.

Kang J, Fulop G, Friedman AH.

Acta Ophthalmol (Copenh). 1988 Aug;66(4):407-12.

PMID:
3195321
9.
10.

The value of alpha-amylase and isoamylase determination in chronic renal failure patients.

Tsianos EV, Dardamanis MA, Elisaf M, Vasakos S, Siamopoulos KC.

Int J Pancreatol. 1994 Apr;15(2):105-11.

PMID:
8071568
11.

Potential role of parathyroid hormone as an inhibitor of erythropoiesis in the anemia of renal failure.

McGonigle RJ, Wallin JD, Husserl F, Deftos LJ, Rice JC, O'Neill WJ Jr, Fisher JW.

J Lab Clin Med. 1984 Dec;104(6):1016-26.

PMID:
6501997
12.

Hair zinc compared with plasma zinc in uremic patients before and during regular hemodialysis.

Mountokalakis T, Dakanalis D, Boukis D, Virvidakis K, Voudiklari S, Koutselinis A.

Clin Nephrol. 1979 Nov;12(5):206-9.

PMID:
509794
13.

Fingernail creatinine as a predictor of prior renal function.

Bergamo RR, Laidlaw SA, Kopple JD.

Am J Kidney Dis. 1993 Dec;22(6):814-21.

PMID:
8250028
14.

Determination of dextromethorphan metabolic phenotype by salivary analysis with a reference to genotype in Chinese patients receiving renal hemodialysis.

Hou ZY, Chen CP, Yang WC, Lai MD, Buchert ET, Chung HM, Pickle LW, Woosley RL.

Clin Pharmacol Ther. 1996 Apr;59(4):411-7.

PMID:
8612385
15.

Glutathione peroxidase activity in patients with renal disorders.

El-Far MA, Bakr MA, Farahat SE, Abd El-Fattah EA.

Clin Exp Nephrol. 2005 Jun;9(2):127-31.

PMID:
15980946
16.

Paracetamol and its metabolites in saliva and plasma in chronic dialysis patients.

Lee HS, Ti TY, Lye WC, Khoo YM, Tan CC.

Br J Clin Pharmacol. 1996 Jan;41(1):41-7.

17.

Plasma levels of endothelin in chronic renal failure and after renal transplantation: impact on hypertension and cyclosporin A-associated nephrotoxicity.

Stockenhuber F, Gottsauner-Wolf M, Marosi L, Liebisch B, Kurz RW, Balcke P.

Clin Sci (Lond). 1992 Mar;82(3):255-8.

PMID:
1312409
18.

Accumulation of vitamin E metabolites in the blood of renal failure patients.

Galli F, Floridi AG, Floridi A, Buoncristiani U.

Clin Nutr. 2004 Apr;23(2):205-12.

PMID:
15030960
19.

Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.

De Martin S, Orlando R, Bertoli M, Pegoraro P, Palatini P.

Clin Pharmacol Ther. 2006 Dec;80(6):597-606.

PMID:
17178261
20.

Pyridinium crosslinks in patients on haemodialysis and continuous ambulatory peritoneal dialysis.

Ibrahim S, Mojiminiyi S, Barron JL.

Nephrol Dial Transplant. 1995 Dec;10(12):2290-4.

PMID:
8808228

Supplemental Content

Support Center